Castle Biosciences (CSTL) PT Raised to $42 at Canaccord Genuity
Tweet Send to a Friend
(Updated - October 29, 2024 6:30 AM EDT)
Canaccord Genuity analyst Kyle Mikson raised the price target on Castle ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Kyle Mikson raised the price target on Castle ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
